Guidelines on the Management of Stable Angina Pectoris ... - Cardio

60 ESC <strong>Guidelines</strong>547. Yoshio H, Shimizu M, Kita Y, Ino H, Kaku B, Taki J et al. Effects of shorttermaminophylline administration on cardiac functional reserve inpatients with syndrome X. J Am Coll Cardiol 1995;25:1547–1551.548. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Papacci F, Visocchi M et al.Effect of spinal cord stimulation on spontaneous and stress-inducedangina and ‘ischemia-like’ ST-segment depression in patients withcardiac syndrome X. Eur Heart J 2005;549. Eriksson BE, Tyni-Lenne R, Svedenhag J, Hallin R, Jensen-Urstad K,Jensen-Urstad M et al. Physical training in Syndrome X: physicaltraining counteracts deconditioning and pain in Syndrome X. J AmColl Cardiol 2000;36:1619–1625.550. Sitges M, Heras M, Roig E, Duran M, Masotti M, Zurbano MJ et al. Acuteand mid-term combined hormone replacement therapy improves endothelialfunction in post-menopausal women with angina and angiographicallynormal coronary arteries. Eur Heart J 2001;22:2116–2124.551. Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P et al.17-beta-Estradiol therapy lessens angina in postmenopausal womenwith syndrome X. J Am Coll Cardiol 1996;28:1500–1505.552. Chevalier P, Dacosta A, Defaye P, Chalvidan T, Bonnefoy E, Kirkorian Get al. Arrhythmic cardiac arrest due to isolated coronary arteryspasm: long-term outcome of seven resuscitated patients. J Am CollCardiol 1998;31:57–61.553. Ricci DR, Orlick AE, Cipriano PR, Guthaner DF, Harrison DC. Alteredadrenergic activity in coronary arterial spasm: insight into mechanismbased on study of coronary hemodynamics and the electrocardiogram.Am J Cardiol 1979;43:1073–1079.554. Lablanche JM, Bauters C, McFadden EP, Quandalle P, Bertrand ME.Potassium channel activators in vasospastic angina. Eur Heart J1993;14(Suppl. B):22–24.555. Khatri S, Webb JG, Carere RG, Dodek A. Stenting for coronary arteryspasm. Catheter Cardiovasc Interv 2002;56:16–20.556. Gaspardone A, Tomai F, Versaci F, Ghini AS, Polisca P, Crea F et al.Coronary artery stent placement in patients with variant angina refractoryto medical treatment. Am J Cardiol 1999;84:96–98. A8.557. Waters DD, Bouchard A, Theroux P. Spontaneous remission is a frequentoutcome of variant angina. J Am Coll Cardiol 1983;2:195–199.558. Jones RH, Kesler K, Phillips HR III, Mark DB, Smith PK, Nelson CL et al.Long-term survival benefits of coronary artery bypass grafting andpercutaneous transluminal angioplasty in patients with coronaryartery disease. J Thorac Cardiovasc Surg 1996;111:1013–1025.559. Myocardial infarction and mortality in the coronary artery surgery study(CASS) randomized trial. N Engl J Med 1984;310:750–758.560. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. Ameta-analysis of randomized controlled trials comparing coronaryartery bypass graft with percutaneous transluminal coronaryangioplasty: one- to 8 year outcomes. J Am Coll Cardiol 2003;41:1293–1304.561. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. Arandomized study of coronary angioplasty compared with bypass surgeryin patients with symptomatic multivessel coronary disease. GermanAngioplasty Bypass Surgery Investigation (GABI). N Engl J Med1994;331:1037–1043.562. Rodriguez A, Rodriguez Alemparte M, Baldi J, Navia J, Delacasa A,Vogel D et al. Coronary stenting versus coronary bypass surgery inpatients with multiple vessel disease and significant proximal LADstenosis: results from the ERACI II study. Heart 2003;89:184–188.563. Goy JJ, Eeckhout E, Moret C, Burnand B, Vogt P, Stauffer JC et al.5 year outcome in patients with isolated proximal left anterior descendingcoronary artery stenosis treated by angioplasty or left internalmammary artery grafting. A prospective trial. Circulation 1999;99:3255–3259.564. Nilsson J, Algotsson L, Hoglund P, Luhrs C, Brandt J. Early mortality incoronary bypass surgery: the EuroSCORE versus The Society of ThoracicSurgeons risk algorithm. Ann Thorac Surg 2004;77:1235–1239; discussion1239–1240.565. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R.European system for cardiac operative risk evaluation (EuroSCORE). EurJ Cardiothorac Surg 1999;16:9–13.566. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG et al. Longtermpatency of saphenous vein and left internal mammary artery graftsafter coronary artery bypass surgery: results from a Department ofVeterans Affairs Cooperative Study. J Am Coll Cardiol 2004;44:2149–2156.567. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Longterm(5 to 12 years) serial studies of internal mammary artery andsaphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg1985;89:248–258.568. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery withinternal-thoracic-artery grafts–effects on survival over a 15-yearperiod. N Engl J Med 1996;334:216–219.569. Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass Ret al. Two internal thoracic artery grafts are better than one. J ThoracCardiovasc Surg 1999;117:855–872.570. Brodman RF, Frame R, Camacho M, Hu E, Chen A, Hollinger I. Routine useof unilateral and bilateral radial arteries for coronary artery bypassgraft surgery. J Am Coll Cardiol 1996;28:959–963.571. Acar C, Ramsheyi A, Pagny JY, Jebara V, Barrier P, Fabiani JN et al.The radial artery for coronary artery bypass grafting: clinical andangiographic results at 5 years. J Thorac Cardiovasc Surg1998;116:981–989.572. van Dijk D, Nierich AP, Jansen EW, Nathoe HM, Suyker WJ, Diephuis JCet al. Early outcome after off-pump versus on-pump coronary bypasssurgery: results from a randomized study. Circulation 2001;104:1761–1766.573. Angelini GD, Taylor FC, Reeves BC, Ascione R. Early and midtermoutcome after off-pump and on-pump surgery in Beating Heart AgainstCardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of tworandomised controlled trials. Lancet 2002;359:1194–1199.574. Khan NE, De Souza A, Mister R, Flather M, Clague J, Davies S et al. A randomizedcomparison of off-pump and on-pump multivesselcoronary-artery bypass surgery. N Engl J Med 2004;350:21–28.575. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al.ACC/AHA guidelines of percutaneous coronary interventions (revision ofthe 1993 PTCA guidelines)–executive summary. A report of theAmerican College of Cardiology/American Heart Association TaskForce on Practice <strong>Guidelines</strong> (committee to revise the 1993 guidelinesfor percutaneous transluminal coronary angioplasty). J Am CollCardiol 2001;37:2215–2239.576. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminalcoronary angioplasty versus medical treatment for non-acute coronaryheart disease: meta-analysis of randomised controlled trials. BMJ2000;321:73–77.577. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty withmedical therapy in the treatment of single-vessel coronary arterydisease. Veterans Affairs ACME Investigators. N Engl J Med1992;326:10–16.578. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronaryangioplasty versus medical therapy for stable angina pectoris: outcomesfor patients with double-vessel versus single-vessel coronary arterydisease in a Veterans Affairs Cooperative randomized trial. VeteransAffairs ACME InvestigatorS. J Am Coll Cardiol 1997;29:1505–1511.579. RITA-2 trial participants. Coronary angioplasty versus medical therapyfor angina: the second Randomised Intervention Treatment of Angina(RITA-2) trial participants. Lancet 1997;350:461–468.580. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM et al.Aggressive lipid-lowering therapy compared with angioplasty in stablecoronary artery disease. Atorvastatin versus RevascularizationTreatment Investigators. N Engl J Med 1999;341:70–76.581. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents.A hierarchical bayesian meta-analysis. Ann Intern Med 2003;138:777–786.582. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB. Impact ofcoronary artery stents on mortality and nonfatal myocardial infarction:meta-analysis of randomized trials comparing a strategy of routinestenting with that of balloon angioplasty. Am Heart J 2004;147:815–822.583. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin Met al. A randomized comparison of a sirolimus-eluting stent with a standardstent for coronary revascularization. N Engl J Med2002;346:1773–1780.584. Lansky AJ, Costa RA, Mintz GS, Tsuchiya Y, Midei M, Cox DA et al.Non-polymer-based paclitaxel-coated coronary stents for the treatmentof patients with de novo coronary lesions: angiographic follow-up of theDELIVER clinical trial. Circulation 2004;109:1948–1954.585. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’ShaughnessyC et al. Sirolimus-eluting stents versus standard stents in patients withstenosis in a native coronary artery. N Engl J Med 2003;349:1315–1323.586. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT et al.A polymer-based, paclitaxel-eluting stent in patients with coronaryartery disease. NEnglJMed2004;350:221–231.